2023 / 01

Next Paper
DOI: 10.24075/brsmu.2023.007
Copyright: © 2023 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Main state industrial policy measures for the pharmaceutical industry of the Russian Federation

Gaydin TY1,2, Geller EV2, Rozhnova SA2, Gaydina TA2
About authors

1 Lomonosov Moscow State University, Moscow, Russia

2 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Timofey Yu. Gaydin
Ostrovityanova, 1, Moscow, 117997, Russia; ur.usm.noce@nidyag

About paper

Author contribution: Gaydin TY, Geller EV — literature analysis, study conduct, manuscript authoring; Rozhnova SA, Gaydina TA — literature analysis, study planning and conduct, manuscript authoring.

Received: 2023-01-30 Accepted: 2023-02-22 Published online: 2023-02-28
|
  1. Dannye roznichnogo audita farmacevticheskogo rynka RF DSM Group. 2022. [citirovano 2023 Yanvar' 28] Dostupno po ssylke: https://dsm.ru/docs/analytics/Июнь%202022%20Итог.pdf. Russian.
  2. Solodova R. Analitika ot GxP News. 2022. [citirovano 2022 Dekabr' 24]. Dostupno po ssylke: https://gxpnews.net/2022/06/farmotrasl-rossii-na-nachalo-2022-goda/. Russian.
  3. DSM Group. Farmacevticheskij rynok Rossii: Dekabr' 2022 g. 2022. [citirovano 2023 Yanvar' 28]. Dostupno po ssylke: https:// dsm.ru/marketing/free-information/analytic-reports/. Russian.
  4. Oborin MS. Problemy i perspektivy importozameshheniya v farmacevticheskoj otrasli. Vestnik NGIEhI. 2021; 5 (120): 101–10. DOI: 10.24412/2227-9407-2021-5-101-110. Russian.
  5. Kurdin A, Shastitko A. The new industrial policy: a chance for the BRICS countries. BRICS Journal of Economics. 2020; 1 (1): 60–80. DOI: 10.38050/2712-7508-2020-5.
  6. Kalinin A. Postroenie sbalansirovannoj promyshlennoj politiki: voprosy strukturirovaniya celej, zadach, instrumentov. Voprosy ehkonomiki. 2012; (4): 132–146. DOI: 10.32609/0042-87362012-4-132-146. Russian.
  7. Korzh NV, Shkatova KV, Supikov V. N. Sovremennye tendencii razvitiya rossijskogo rynka truda. Izvestiya vysshix uchebnyx zavedenij. Povolzhskij region. Obshhestvennye nauki. 2022; 2 (62): 40–51. Russian.
  8. Postanovlenie Pravitel'stva Rossijskoj Federacii ot 05.04.2022 # 593 «Ob osobennostyax obrashheniya lekarstvennyx sredstv dlya medicinskogo primeneniya pri vozniknovenii defektury ili riska vozniknoveniya defektury v svyazi s vvedeniem v otnoshenii Rossijskoj Federacii ogranichitel'nyx mer ehkonomicheskogo xaraktera». 2023. [citirovano 2023 Mart 02]. Dostupno po ssylke: http://publication.pravo.gov.ru/Document/View/0001202204110030?index=0&rangeSize=1. Russian.
  9. Federal'nyj zakon #323 ot 21.11.2011 «Ob osnovax oxrany zdorov'ya grazhdan v RF». 2023. [citirovano 2023 Mart 02]. Dostupno po ssylke: https://www.zakonrf.info/zakon-o-zdorovyegrazhdan/. Russian.
  10. Pooled Procurement of Drugs in Low and Middle Income Countries. [citirovano 2023 Yanvar' 28]. Dostupno po ssylke: https://www.tse-fr.eu/sites/default/files/TSE/documents/doc/ wp/2019/wp_tse_999.pdf.
  11. Scheckel CJ, Vincent Rajkumar S. Drug importation: limitations of current proposals and opportunities for improvement. Blood Cancer Iournal. 2021; 11 (7): 132. DOI: 10.1038/s41408-02100522-3.
  12. Minssen T, Kesselheim AS, Darrow JJ. An export-only exception to pharmaceutical patents in Europe: should the United States follow suit? Nat Biotechnol. 2019; 37 (1): 21–22. DOI: 10.1038/ nbt.4324.
  13. Gaydin TY, Rozhnova SA. Compulsory licensing in pharmaceutical industry: current state of affairs and prospects. Bulletin of RSMU. 2021;(2):5–10. DOI: 10.24075/brsmu.2021.011.
  14. Schuhmacher A, Gassmann O, McCracken N, Hinder M. Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?. Journal of Translational Medicine. 2018; 16 (1): 119. DOI: 10.1186/s12967018-1499-2.
  15. Sokolova SV, Kareva NN, Ivanov AS. Farmacevticheskij rynok: klasternyj vektor razvitiya. Problemy sovremennoj ehkonomiki. 2017; 4 (64): 173–8. Russian.
  16. Dorozhkina TV, Pilgun YaS. Osobennosti razvitiya Kaluzhskogo farmacevticheskogo klastera v usloviyax vneshnix vyzovov: pandemiya koronavirusa. Ehkonomika i biznes: teoriya i praktika. 2020; 51 (63): 169–72. DOI: 10.24411/2411-04502020-10400. Russian.
  17. Dorozhkina TV, Tatarchenko KR, Kuznecova AA. Nacproekt «Mezhdunarodnaya kooperaciya i ehksport»: smeshhenie akcenta na regional'nyj uroven'. Vestnik obrazovatel'nogo konsorciuma Srednerusskij universitet. Seriya: Ehkonomika i upravlenie. 2022; (20): 16–18. Russian.
  18. Chen J, Xie L. Industrial policy, structural transformation and economic growth: evidence from China. Front Bus. Res China. 2019; 13 (18): https://doi.org/10.1186/s11782-019-0065-y.
  19. Lane N. Manufacturing Revolutions: Industrial Policy and Industrialization in South Korea. 2022. 2023. [citirovano 2023 Mart 02]. Dostupno po ssylke: http://dx.doi.org/10.2139/ssrn.3890311.
  20. Huang Z, Lan Y, Zha X. Research on government subsidy strategies for new drug R&D considering spillover effects. PloS One. 2022; 17 (2): e0262655. DOI: 10.1371/journal.pone.0262655.
  21. Postanovlenie Pravitel'stva Moskvy ot 11.02.2016 N 38-PP «O merax po realizacii promyshlennoj i investicionnoj politiki v gorode Moskve». 2023. [citirovano 2023 Mart 02]. Dostupno po ssylke: https://www.mos.ru/depr/documents/view/269724220/. Russian.